Placental amino acid transporters: The critical link between maternal nutrition and fetal programming?

The Placenta and Human Developmental Programming

Volumn , Issue , 2010, Pages 147-160

  Jansson, Thomas ^a   Powell, Theresa L ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890829222     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511933806.013     Document Type: Chapter

References (75)

1. Jansson T, Powell TL. Placental nutrient transfer and fetal growth. Nutrition2000; 16: 500–2.
2. Jansson T, Powell TL. Human placental transport in altered fetal growth: does the placenta function as a nutrient sensor? – a review. Placenta 2006; 27 Suppl: 91–7.
3. Jansson T, Powell TL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional appraoches. Clin Sci2007; 113: 1–13.
4. Myatt L. Placental adaptive responses and fetal programming. J Physiol2006; 572: 25–30.
5. Fowden AL, Forhead AJ, Coan PM, Burton GJ. The placenta and intrauterine programming. J Neuroendocrinol2008; 20: 439–50.
6. Jones HN, Powell TL, Jansson T. Regulation of placental nutrient transport. A review. Placenta2007; 28: 763–74.
7. Sibley CP, Turner MA, Cetin I et al.Placental Phenotypes of Intrauterine Growth. Pediatr Res2005; 58: 827–32.
8. Marconi AM, Paolini CL. Nutrient transport across the intrauterine growth-restricted placenta. Semin Perinatol2008; 32: 178–81.
9. Hoffman L, Mandel TE, Carter WM, Koulmanda M, Martin FIR. Insulin secretion by fetal human human pancreas in organ culture. Diabetologia1982; 23: 426–30.
10. Gulati P, Gaspers LD, Dann SG et al.Amino acids activate mTOR Complex 1 via Ca2+/CaM signaling to hVps34. Cell Metab2008; 7: 456–65.
11. Sturman J. Taurine in development. J Nutr1988; 118: 1169–76.
12. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med2008; 359: 61–73.
13. Cleal JK, Lewis RM.The mechanisms and regulation of placental amino acid transport to the human fetus. J Neuroendocrinol2008; 20: 419–26.
14. Moe AJ. Placental amino acid transport. Am J Physiol1995; 268: C1321-C31.
15. Jansson T. Amino acid transporters in the human placenta. Pediatr Res2001; 49: 141–7.
16. Mackenzie B, Erickson JD. Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family. Pflugers Arch2004; 447: 784–95.
17. Desforges M, Lacey HA, Glazier JD et al. The SNAT4 isoform of the system A amino acid transporter is expressed in human placenta. Am J Physiol Cell Physiol2006; 290: C305–C12.
18. Verrey F, Closs EI, Wagner CA, Palacin M, Endou H, Kanai Y. CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch2003.
19. Dicke JM, Henderson GI. Placental amino acid uptake in normal and complicated pregnancies. Am J Med Sci1988; 295(3): 223–7.
20. Mahendran D, Donnai P, Glazier JD et al.Amino acid (System A) transporter activity in microvillous membrane vesicles from the placentas of appropriate and small for gestational age babies. Pediatr Res1993; 34: 661–5.
21. Glazier JD, Cetin I, Perugino G et al.Association between the activity of the system A amino acid transporter in the microvillous plasma membrane of the human placenta and severity of fetal compromise in intrauterine growth restriction. Pediatr Res1997; 42: 514–19.
22. Jansson T, Ylvén K, Wennergren M, Powell TL. Glucose transport and system A activity in syncytiotrophoblast microvillous and basal membranes in intrauterine growth restriction. Placenta2002; 23: 386–91.
23. Shibata E, Hubel CA, Powers RW et al. Placental System A amino acid transport is reduced in pregnancies complicated with small for gestational age (SGA) infants but not in preecalmpsia with SGA infants. Placenta2008; 29: 879–82.
24. Jansson T, Ekstrand Y, Björn C, Wennergren M, Powell TL. Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes2002; 51: 2214–19.
25. Kuruvilla AG, D’Souza SW, Glazier JD et al.Altered activity of the system A amino acid transporter in microvillous membrane vesicles from placentas of macrosomic babies born to diabetic women. J Clin Invest1994; 94: 689–95.
26. Jansson T, Scholtbach V, Powell TL. Placental transport of leucine and lysine is reduced in intrauterine growth restriction. Pediatr Res1998; 44: 532–7.
27. Paolini CL, Marconi AM, Ronzoni S et al.Placental transport of leucine, phenylalanine, glycine, and proline in intrauterine growth-restricted pregnancies. J Clin Endocrinol Metab2001; 86: 5427–32.
28. Jansson N, Pettersson J, Haafiz A et al.Downregulation of placental transport of amino acids precedes the development of intrauterine growth restriction in rats fed a low protein diet. J Physiol (Lond)2006; 576: 935–46.
29. Karl PI, Alpy KL, Fischer SE. Amino acid transport by the cultured human placental trophoblast: effect of insulin on AIB transport. Am J Physiol1992; 262: C834–C9.
30. Bloxam DL, Bax BE, Bax CMR. Epidermal growth factor and insulin-like growth factor I differentially influence the directional accumulation and transfer of 2-aminoisobutyrate (AIB) by human placental trophoblast in two-sided culture. Biochim Biophys Res Commun1994; 199: 922–9.
31. Kniss DA, Shubert PJ, Zimmerman PD, LandonMB, Gabbe SG. Insulin growth factors: their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester chorionic villi. J ReprodMed1994; 39: 249–56.
32. Karl PI. Insulin-like growth factor-1 stimulates amino acid uptake by the cultured human placental trophoblast. J Cell Physiol1995; 165: 83–8.
33. Nandakumaran M, Makhseed M, Al-Rayyes S, Akanji AO, Sugathan TN. Effect on transport kinetics of alpha-aminoisobutyric acid in the perfused human placental lobule in vitro. Pediatr Int2001; 43: 581–6.
34. Jansson N, Greenwood S, Johansson BR, Powell TL, Jansson T. Leptin stimulates the activity of the system A amino acid transporter in human placental villous fragments. J Clin Endocrinol Metab2003; 88: 1205–11.
35. Jones HN, Ashworth CJ, Page KR, McArdle HJ. Expression and adaptive regulation of amino acid transport system A in a placental cell line under amino acid restriction. Reproduction2006; 131: 951–60.
36. Nelson DM, Smith SD, Furesz TC et al.Hypoxia reduces expression and function of system A amino acid transporters in cultured term human trophoblasts. Am J Physiol2003; 284: C310–C5.
37. Jones HN, Ashworth CM, Page KR, McArdle HJ. Cortisol stimulates System A amino acid transport and SNAT2 expression in a human placental cell line (BeWo). Am J Endocrinol Metab2006; 291: E596–E603.
38. Khullar S, Greenwood SL, McCord N, Glazier JD, Ayuk PT. Nitric oxide and superoxide impair human placental amino acid uptake and increase Na+ permeability: implications for fetal growth. Free Radical Biol Med2004; 36: 271–7.
39. Ramamoorthy S, Leibach FH, Mahesh VB, Ganapathy V. Modulation of the activity of amino acid transport system L by phorbol esters and calmodulin antagonists in a human placental choriocarcinoma cell line. Biochim Biophys Acta1992; 1136: 181–8.
40. Brandsch M, Leibach FH, Mahesh VB, Ganapathy V. Calmodulin-dependent modulation of pH sensitivity of the amino acid transport system L in human placental choriocarcinoma cells. Biochim Biophys Acta1994; 1192: 177–84.
41. Okamoto Y, Sakata M, Ogura K et al. Expression and regulation of 4Fhc and hLAT1 in human trophoblasts. Am J Physiol Cell Physiol2002; 282: C196–C204.
42. Jones HN, Jansson T, Powell TL. IL-6 stimulates System A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2. Am J Physiol Cell2009; 297: C1228–35.
43. Jones HN, Jansson T, Powell TL. Full length adiponectin attenuates insulin signaling and inhibits insulin-stimulated amino acid transport in human primary trophoblast cells. Diabetes2010; 59: 1161–70.
44. Peng T, Golub TR, Sabatini DM. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation.Mol Cell Biol2002; 22(15): 5575–84.
45. Tee AR, Blenis J. mTor, translational control and human disease. Semin Cell Dev Biol2005; 16: 29–37.
46. Martin DE, Hall MN. The expanding TOR network. Curr Opin Cell Biol2005; 17: 158–66.
47. Hay N, Soneneberg N. Upstream and downstream of mTOR. Genes Dev2004; 18: 1926–45.
48. Jacinto E, Hall MN. TOR signalling in bugs, brain and brawn. Nature Rev Mol Cell Biol2003; 4: 117–26.
49. Roos S, Jansson N, Palmberg I, Säljö K, Powell TL, Jansson T. Mammalian target of rapamycin in the human placenta regulates leucine transport and is downregulated in restricted foetal growth. J Physiol2007; 582: 449–59.
50. Roos S, Kanai Y, Prasad PD, Powell TL, Jansson T. Regulation of placental amino acid transporter activity by mammalian target of rapamycin. Am J Physiol Cell2009; 296: C142–C50.
51. Roos S, Lagerlöf O, Wennergren M, Powell TL, Jansson T. Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is mediated by mTOR signaling. Am J Physiol Cell2009; 297: C723–C31.
52. Strid H, Bucht E, Jansson T, Wennergren M, Powell T. ATP-dependent Ca2+ transport across basal membrane of human syncytiotrophoblast in pregnancies complicated by diabetes or intrauterine growth restriction. Placenta2003; 24: 445–52.
53. Strid H, Care AD, Jansson T, Powell TL. PTHrp midmolecule stimulates Ca2+ ATPase in human syncytiotrophoblast basal membrane. J Endocrinol2002; 175: 517–24.
54. Godfrey KM, Matthews N, Glazier J et al.Neutral amino acid uptake by microvillous plasma membrane of the human placenta is inversely related to fetal size at birth in normal pregnancy. J Clin Endocrinol Metab1998; 83: 3320–6.
55. Constancia M, Hemberger M, Hughes J et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature2002; 417: 945–8.
56. Constancia M, Angiolini E, Sandovici I et al. Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. Proc Natl Acad Sci USA2005; 102: 19219–24.
57. Coan PM, Burton GJ, Ferguson-Smith AC. Imprinted genes in the placenta: a review. Placenta2006; 26 (Suppl A): S10–S20.
58. Masuzaki H, Ogawa Y, Sagawa N et al.Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nature Med1997; 3: 1029–33.
59. Reis FM, Florio P, Cobellis L et al.Human placenta as a source of neuroendocrine factors. Biol Neonate2001; 79: 150–6.
60. Desoye G, Hartmann M, Blaschitz A et al.Insulin receptors in syncytiotrophoblast and fetal endothelium of human placenta. Immunohistochemical evidence for developmental changes in distribution pattern. Histochemistry1994; 101: 277–85.
61. Ebenbichler CF, Kasser S, Laimer M et al. Polar expression and phosphorylation of human leptin receptor isoforms in paired syncytial, microvillous and basal membranes from human term placenta. Placenta2002; 23: 516–21.
62. Fang J, Furesz TC, Lurent RS, Smith CH, Fant M. Spatial polarization of insulin-like growth factor receptors on the human syncytiotrophoblast. Pediatr Res1997; 41: 258–65.
63. Holmes R, Montemagno R, Jones J et al.Fetal and maternal plasma insulin-like growth factors in pregnancies with appropriate or retarded fetal growth. Early Hum Dev1997; 49: 7–17.
64. Yildiz L, Avci B, Ingec M. Umbilical cord and maternal blood leptin concentrations in intrauterine growth retardation. Clin Chem Lab Med2002; 40: 1114–17.
65. Lauszus FF, Klebe JG, Flyvbjerg A. Macrosomia associated with maternal serum insulin-like growth factor-I and -II in diabeteic pregnancy. Obstet Gynecol2001; 97: 734–41.
66. Jansson N, Nilsfelt A, Gellerstedt M et al. Maternal hormones linking maternal body mass index and dietary intake to birth weight. Am J Clin Nutr2008; 87: 1743–9.
67. Malandro MS, Beveridge MJ, Kihlberg MS, Novak DA. Effect of low-protein diet-induced intrauterine growth retardation on rat placental amino acid transport. Am J Physiol1996; 271: C295–C303.
68. Jones HN, Woollett LP, Barbour N et al.High fat diet before and during pregnancy causes marked upregulation of placental nutrient transport and fetal overgrowth in C57/Bl6 mice. FASEB J2009; 23: 271–8.
69. Ogden CL, Caroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA2006; 295: 1549–55.
70. Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Publ Health2001; 91: 436–40.
71. Sebire NJ, Jolly M, Harris JP et al.Maternal obesity and pregnancy outcome: a study of 287, 213 pregnancies in London. Int J Obes Relat Metab Disord2001; 25: 1175–82.
72. Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med1998; 338(3): 147–52.
73. Boney CM, Verma A, Tucker R, Vohr BS. Metabolic syndrome in childhood: Association with birth weight, maternal obesity, and gestational diabetes. Pediatrics2005; 115: e290–e6.
74. Ramsay JE, Greer I, Sattar N. Obesity and reproduction. Br Med J2006; 333: 1159–62.
75. Hendler I, Blackwell SC, Metha SH et al.The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol2005; 193: 979–83.